For the Quarter Ending March 2024
North America
In Q1 2024, the pricing dynamics of Metoprolol Succinate in the North America region, specifically in the USA, were influenced by a range of factors. The market situation in the USA played a significant role in shaping the pricing dynamics. The overall trend was characterized by an increase in prices in January, followed by decline in February and March 2024.
At the beginning of the quarter, prices for Metoprolol Succinate experienced a moderate increase, driven by heightened buying activity in downstream sectors, improved consumer confidence, and disruptions in transportation logistics. However, this upward trend was short-lived as consumer attitudes towards the economy grew increasingly cautious, reflecting a broader trend of uncertainty fueled by sluggish retail sales and subdued consumer spending. Persistent inflationary pressures further exacerbated this cautiousness, prompting consumers to adopt a more conservative approach to their finances. The Federal Reserve's obligation to implement higher interest rates to counteract inflationary pressures added to the financial strain experienced by consumers. Consequently, this has curbed their purchasing power, leading to a lower overall demand for Metoprolol Succinate in the USA market.
Despite the overall price increase in Q1 2024, there was a year-over-year decrease of 12% compared to the same quarter last year. The price at the end of the quarter was USD 57200/MT. It is important to note that the pricing dynamics in the Metoprolol Succinate market are influenced by a range of factors, and a nuanced analysis is necessary to understand the complex dynamics at play.
Asia Pacific
In Q1 2024, the pricing trends of Metoprolol Succinate in the APAC region were influenced by a variety of factors, reflecting a dynamic and volatile market environment. Notably, the market in China exhibited a mixed performance, with a significant year-over-year price increase of 29% compared to the same quarter last year, indicating heightened volatility compared to previous periods. The quarter began with a slight price increase in January, driven by improved manufacturing activities spurred by heightened demand across sectors such as healthcare and pharmaceuticals. Furthermore, expanding export orders indicated a slight uptick in overseas demand, contributing to the upward trajectory of prices. However, prices experienced a decline in February and March, attributed to reduced demand exacerbated by a global economic slowdown impacting Chinese exports. The closure of numerous companies during the Spring Festival in China also played a role in the decreased demand and oversupply in the market. Moreover, disruptions in the global supply chain caused by tensions in the Red Sea further affected exports from China, impacting pricing dynamics. The final quarter's price for Metoprolol Succinate (USP, FDA) FOB Shanghai in China was USD 56000/MT.
Europe
During Q1 2024, the pricing dynamics of Metoprolol Succinate in the Europe region were subject to a multitude of influences. At the onset of the quarter, prices experienced a slight increase amid a complex blend of geopolitical tensions, logistical challenges, and diminishing inventories. Despite these obstacles, downstream industries maintained a steady operational rhythm, fostering consistent demand for Metoprolol Succinate and consequently driving prices upwards. However, this upward trend was short-lived as prices began to decline thereafter, driven by a decrease in demand from various end-user industries. Additionally, there was a notable decrease in new orders, particularly within the domestic market, which further exacerbated the downward trajectory of prices. The market conditions in Germany were particularly unstable, characterized by economic challenges in the manufacturing sector and a decline in consumer sentiment. Furthermore, the decision of the central bank to maintain unchanged interest rates in March added to the burden on consumers. Also, the supply of Metoprolol Succinate remained adequate, with market participants actively clearing their existing stock at lower prices. In conclusion, the final quarter's price for Metoprolol Succinate (USP, FDA) CFR Hamburg in Germany stood at USD 56800 per metric ton.
For the Quarter Ending December 2023
North America
Metoprolol Succinate pricing in the North America region during the fourth quarter of 2023 was influenced by several factors. Firstly, the market experienced a stable to bearish trend, with prices declining by 1.26% compared to the previous quarter. This decline can be attributed to weak demand caused by escalating inflation and elevated interest rates, which limited the purchasing power of consumers.
In the United States, which saw the most significant changes in prices, Metoprolol Succinate prices increased by 0.72% and 0.64% in October and November respectively, driven by a pickup in business output and a moderate easing of inflationary pressures. However, prices declined by 2.74% in December due to a decrease in demand from end-sectors and lower consumer confidence. With a surplus in supply and potentially lower demand, manufacturers and distributors responded by offering lower quotations to clear excess inventory, especially towards the end of the year.
Overall, the North America market for Metoprolol Succinate experienced a mix of stable and bearish conditions, with prices fluctuating based on the demand-supply dynamics and the economic climate. The latest price for Metoprolol Succinate (USP, FDA) CFR Los Angeles in the USA at the end of the fourth quarter was USD 57750/MT.
APAC
The APAC region experienced mixed market conditions for Metoprolol Succinate during the fourth quarter of 2023. The market was influenced by several factors. Firstly, the overall demand for Metoprolol Succinate remained weak, primarily due to subdued new orders and purchases from both domestic and international markets. Secondly, there was an adequate supply of Metoprolol Succinate in the market, which contributed to stable pricing. However, the market was also affected by the global economic uncertainties and geopolitical challenges, which created a cautious sentiment among market participants. In China, which is one of the major players in the Metoprolol Succinate market, the prices experienced a moderate increase in October and November due to constrained supplies and a surge in demand from consumers during the festive season. However, the prices declined in December, attributed to reduced inquiries from downstream industries and sluggish exports to foreign nations. Furthermore, disruptions in the global supply chain, arising from tensions in the Red Sea, affected the exports of Asian countries The latest price of Metoprolol Succinate (USP, FDA) FOB Shanghai in China for the current quarter is USD 57000/MT.
Europe
In the fourth quarter of 2023, the pricing of Metoprolol Succinate in the European region was impacted by several factors. Firstly, there was a decline in demand from end-users, particularly in the healthcare and pharmaceutical sectors. This can be attributed to the persistent inflationary pressures and high interest rates, which constrained consumer spending. Secondly, there was an abundant supply of Metoprolol Succinate in the market, leading to a decrease in prices. This was a result of reduced market demand and the implementation of higher interest rates by the European Central Bank. Finally, the overall market dynamics in Germany, the country with the maximum price changes, played a significant role in determining Metoprolol Succinate prices. Germany experienced a decline in consumer confidence and a slowdown in its industrial sector, contributing to lower demand and prices. In terms of price trends and seasonality, there was a 0.66% increase in Metoprolol Succinate prices in November, followed by a 0.74% decrease in December. The price in the last quarter of 2023 (Oct-Dec) showed no change compared to the same quarter in the previous year. Additionally, there was no significant price difference between the first and second halves of the quarter. The latest price of Metoprolol Succinate (USP, FDA) CFR Hamburg in Germany for the current quarter is USD 58650/MT.
For the Quarter Ending September 2023
North America
Prices for Metoprolol Succinate in the United States were inconsistent in the third quarter. Prices rose 0.99% and 0.45% in July and August due to inventory replenishment, increased demand from end-user industries, and fewer imports from important exporting nations such as China. In July, consumer prices increased by 3.2 percent, raising company expenses and adding to the price increase. Prices continued to grow in August, with gasoline and fuel oil prices rising by 9.1% and 10.6%, respectively, resulting in increased company expenses and transportation costs. Furthermore, factors such as rising warehousing charges, a lack of storage space, and inventory replenishment all contributed to this upward trend. Prices fell by 12.17 percent in September owing to rising fuel prices and high-interest rates, which led to greater economic uncertainty and weakened consumer confidence. Manufacturers reported another drop in new orders, with the greatest pace of contraction contributing to the negative trend. As a result, firms have been forced to liquidate their amassed inventory and stock in order to maintain profitability.
Asia Pacific
Metoprolol Succinate prices in the Chinese market showed a mixed trend in the third quarter. Prices rose by 1.56% and 0.62% in July and August, respectively, before falling by 12.11 percent in September. Prices originally soared owing to increased demand from both domestic and foreign markets, as well as a scarcity of supply in the market. The manufacturing sector remained in recession but improved in July compared to the previous scenario, indicating that industrial production efficiency increased marginally due to increased market demand. Increased demand from local and international markets prompted businesses to boost their selling prices, contributing to the rising trend. Prices rose further in August as a result of a significant increase in new orders and export sales from the previous month, leading to an increase in overall cost. The Chinese manufacturing sector returned to the expansion zone in September, and business activities increased at a faster rate. Even though supply increased, slow overseas demand continued to weigh on the outlook, keeping the Metoprolol Succinate market on the lower side.
Europe
Metoprolol succinate prices in Germany exhibited a mixed development in the third quarter. Prices rose by 1.00% and 0.53% in July and August, respectively, before falling by 11.96% in September. The inflation rate, as measured by CPI (Consumer Prices Index), was 6.2 percent in July, compared to 6.4 percent in June. The score suggested that inflation eased in July, putting consumer confidence on the positive side. Costs rose further in August due to rising inflation, which was driven by increases in energy and oil prices, raising the expense of firms maintaining APIs (Active Pharmaceutical Ingredients). However, Germany's industrial sector, which accounts for around one-fifth of the country's economy, remained in a downturn in September due to slow demand and rapidly dropping output, causing Metoprolol Succinate prices to fall. In September, the European Central Bank agreed to raise interest rates for the eleventh time in a row to battle persistent inflation, which has maintained market demand on the low side and sustained the downward trend.
For the Quarter Ending June 2023
North America
Metoprolol succinate prices in the United States showed a mixed trend in the second quarter. Prices rose 0.61% in May due to increased end-user demand coupled with new inventory replenishment activities, which kept the market favorable. The manufacturing PMI (Purchasing Managers Index) hit 48.4 in May, indicating a slowdown in the US manufacturing sector. This shows that supply from manufacturers and suppliers has been constrained due to reduced business activity. But consumer demand remained strong, leading to higher prices for metoprolol succinate in May. On the other hand, prices fell 0.75% in June versus May due to unusually sluggish offtakes in end-user industries. Domestic suppliers have ample stock of Metoprolol Succinate, leading to continuously falling costs in the domestic market. Furthermore, high-interest rates by Federal Reserve reduced the demand for metoprolol succinate in the market, further supporting the downtrend. In addition, the appreciation of the US dollar against the Chinese yuan in June increased imports into the US market, resulting in increased supply which further put downward pressure on the price of metoprolol succinate.
Asia Pacific
Metoprolol succinate prices in China showed mixed trends in the second quarter. Metoprolol succinate prices rose 0.78% in May, in contrast to April levels, due to consistent domestic demand and ongoing operational activity. China's purchasing managers' index (PMI) fell to 48.8 in May from 49.2 in April, signaling a slowdown in factory activity, leading to a reduction in inventories among manufacturers and market suppliers to meet strong market demand, pushing prices higher. In contrast, the price of metoprolol succinate fell 0.78% in June from May due to the decline in new orders and slowing consumer purchasing activity. The official manufacturing Purchasing Managers' Index (PMI) rose to 49.0 in June from 48.8 in the previous month, signaling a slowdown in manufacturing activity. Production decreased due to weak demand from end users. However, prices are kept low as market participants hold enough inventory to meet current market demand. In addition, China's exports fell 12.4% in June, leading to an increase in the availability of metoprolol succinate in the Chinese market, supporting the downward trend.
Europe
In Germany, the situation of Metoprolol Succinate showed a mixed trend throughout the second quarter. Prices rose slightly in May to 0.57% from April, then fell to 0.87% in June. Prices rose in May due to limited stockpiles among traders and suppliers, coupled with increased demand from end-user industries. The manufacturing Purchasing Managers' Index (PMI) for Germany fell to 43.2 in May from 44.5 in April, reflecting weaker business activity, and lower inventories among market participants with delays in shipments to meet demand, leading to an increase in Metoprolol Succinate prices. In June, the German economy was hit by rising inflation and an interest rate hike by the European Central Bank, leading to higher food and energy prices. This has increased the cost of living and reduced consumer purchasing activity, supporting the downward trend in the price of Metoprolol Succinate. In addition, the appreciation of the Euro against the US dollar in June made imports cheaper and also increased the supply of metoprolol succinate in the German market. This puts additional downward pressure on prices.
For the Quarter Ending March 2023
North America
The first quarter of 2023 saw a decremented price trend for Metoprolol Succinate because of decreased domestic demand coupled with adequate supplies among the market participants. In Early January, prices displayed an incremented trend which was balanced with the supplies among the local merchants. Also, an easing of trade activity and an improvement in inflation had an impact on the general market trend. Moreover, from the start of February till the termination of Q1, the markets in the U.S. improved to some extent; however, the demand from various sectors decreased owing to which domestic retailers pulled back their newer orders from export nations and focused on destocking their piled-up stocks. Overall, the prices for Metoprolol Succinate were assembled at USD 66000 /MT CFR Los Angeles in the United States.
Asia Pacific
In the APAC region, Metoprolol Succinate prices witnessed a decrement throughout the first quarter of 2023. During the first half of the first quarter of 2023, the market sentiments somewhat improved in China during the holiday-shortened month of January, majorly because of higher demands following the Lunar New Year as both consumption and production increased significantly as the government abandoned its zero-COVID policy. Following February, the prices started to decline at a moderate rate and continued to follow a similar trend until the final week of March 2023. This propels the manufacturers to reduce their production activity and destock the inventories to maintain their profit margin. With this, the prices of Metoprolol Succinate in China were recorded at USD 64700/MT FOB Shanghai,
Europe
In Europe, the price for Metoprolol Succinate tumbled throughout the first quarter of 2023, following the trend of the APAC region. A decline in demand from the end-user industry, a weaker consumer index, and higher stockpiles were some of the factors that kept the prices of Metoprolol Succinate in the downward direction. However, cheaper imports from the APAC region still did not affect the overall market trend of Metoprolol Succinate this quarter. As February draws near reduction in freight charges owing to ease in the logistical problems with more than enough cargo capacity on ships and no longer any traffic at German ports did not affect the market trend because the inquiries remained on the lower side. Overall, consistent feeble demand and lower customer interest resulted in higher stockpiles of Metoprolol Succinate among the market players, which in turn supported the decremented price trend in Germany. With this, the prices for Metoprolol Succinate were settled at USD 3200000/MT CFR Hamburg.
For the Quarter Ending December 2022
North America
The prices of Metoprolol Succinate in North America demonstrated an inclined price trajectory over the first part of the fourth quarter. Increased end-user demand from the pharmaceutical sector kept the prices of Metoprolol Succinate on the higher side. Furthermore, with the start of mid-q4, the prices began to fall gradually owing to a reduction in offtakes and supplies within the domestic market. Also, Supply chain disruption decreased rapidly over the six months to November across multiple measures, which did not affect the market sentiments of Metoprolol Succinate prices as the inventories with market participants were enough to meet any immediate order. Moreover, owing to a significant drop in its offtakes and New year holidays, which resulted in a temporary shutdown of the market within the region, the prices of Metoprolol Succinate remained on the North side and were recorded at USD 206000/ MT CFR Los Angeles.
APAC
In the Asia Pacific region, specifically in China- Metoprolol Succinate prices plummet during the final quarter of 2022. As per the trend, in the first half of q4, the prices inclined on the positive side owing to the healthy downstream demand. The prices dropped again, showing a declining trend on account of weak demand. With the end of the year 2022, China's manufacturing activities began to decrease noticeably as a surge in COVID-19 cases. Moreover, the decrease in freight charges additionally supported the price trend of Metoprolol Succinate. Overall, the prices of Metoprolol Succinate recorded at the end of the fourth quarter were assembled at USD 194250 /MT FOB Shanghai.
Europe
In the fourth quarter of 2022, the European market for Metoprolol Succinate followed a similar pattern as that of North America. The market trend initially started on a healthy note up to November as the demand from the end-user sector pharmaceutical industry remained high. Furthermore, inquiries from the downstream sector for Metoprolol Succinate prices began to decrease gradually in November, keeping the prices on the lower side. Towards the end of the year 2022, fresher orders declined in December as a result of suppliers having large stock levels as a result of the market's brief closure. With this, the prices of Metoprolol Succinate witnesses were assembled at USD 216500/MT CFR Hamburg in Germany.
For the Quarter Ending September 2022
North America
The prices of Metoprolol Succinate witnessed a mixed sentiment in the North American region in the third quarter of 2022. At the onset of Q3, the prices went down owing to the weakened downstream demand from the end-user pharmaceutical sector. Adequate inventories in the domestic market have forcibly pressurized Metoprolol Succinate market sentiments to be on the lower side. Additionally, towards the end of the first half of Q3, the prices begin to rise slightly owing to an increase in the demand balanced by the supply side. Furthermore, the prices declined again in the month of September with -1.91% and got settled at USD 205000/MT CFR Los Angeles in the United States.
APAC
The Asia Pacific region showcased a heightened pricing trend toward Metoprolol Succinate during the third quarter of 2022 owing to the high demand and limited inventories in the downstream pharmaceutical industries; also, Metoprolol Succinate prices rose in China till the second half of Q3. Besides that, the ongoing Covid shutdown in some cities of China has also impacted the market sentiments of Metoprolol Succinate. However, Metoprolol Succinate prices decreased at the end of the quarter because of a piling up of deliveries, due to which the manufacturers were compelled to reduce their quotations. Overall, the prices of Metoprolol Succinate by the quarter ending June were assessed at USD 194000 /MT FOB Shanghai in China.
Europe
During the third quarter of 2022, Metoprolol Succinate witnessed a decremented pricing sentiment in Europe. In the first half of Q3, Metoprolol Succinate prices in the European market climbed at a stable rate due to moderate demand which was balanced by the supply side from the end-user pharmaceutical sector. Furthermore, towards the end of the first half of Q3, the prices started to decline significantly owing to lower importing activities from China amidst lockdown restrictions, causing limited inventories in the regional market of Europe. Logistical issues coupled with a stockpiled of containers drove down the price value of Metoprolol Succinate across the regional market. Overall, the prices of Metoprolol Succinate by the quarter ending September were assessed at USD 215500/MT CFR Hamburg in Germany.
For the Quarter Ending June 2022
North America
The overall market trend of Metoprolol Succinate followed the uptrend during the second quarter of 2022 on account of stagnant demand for the product in the regional market. USA imports the API from China and faces a frenzy supply to produce ample drugs according to the domestic demand. Till the mid-quarter, the market sentiments of Metoprolol Succinate moved in stagnant momentum. Towards the quarter end, the prices rose as the demand and freight charges rose in the regional market. Furthermore, the production activity in the country remained high, consequently impacting the prices of Metoprolol Succinate in the regional market. Towards the end of Q2 of 2022, Metoprolol Succinate was assessed at USD 210000/MT for CFR Los Angeles during June 2022.
Asia-Pacific region
In the second quarter of 2022, the market prices of Metoprolol Succinate observed mixed sentiments in the regional market as the prices tumbled towards the quarter end. China, one of the API's major producers, faced challenges in the quarter as the country went under lockdown. Natural calamities and restricted movement in the country halted the operational rate of Metoprolol Succinate API. This decrement in production showcased the impact on the market prices of Metoprolol Succinate throughout the quarter. Demand from the elderly population of the region remained active as the API is used to treat high blood pressure and reduce the chances the strokes. These facets governed the market sentiments of Metoprolol Succinate in the regional market. Towards the end of Q2 of 2022, Metoprolol Succinate was assessed at INR 3290000/MT for Ex Mumbai during June 2022.
Europe
In the second quarter of 2022, the prices of Metoprolol Succinate followed the upwards trajectory in the European market on the back of surging demand from downstream drug manufacturing units. The transportation of the API remained rough in the European region leading to high production costs. Transportation of the API from China became a frenzy as port congestion occurred in major ports of China. Furthermore, the regional market faced commodity inflation, proportionally raising the prices of feed, energy cost, and transportation costs. The demand for the API came from drug manufacturing plants as people suffer more from high blood pressure and heart stroke diseases. Towards the end of Q2 of 2022, Metoprolol Succinate was assessed at USD 220000/MT for CFR Hamburg during June 2022.
